Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.87 +0.44 (+102.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Prepaid Assets (2020 - 2026)

Werewolf Therapeutics (HOWL) posted quarterly Prepaid Assets of $905000.0 for Q2 2026, down 68.17% year-over-year from $2.8 million in Q2 2025, and down 60.38% on a QoQ basis from $2.3 million in Q1 2026.

Werewolf Therapeutics (HOWL) Prepaid Assets (2020 - 2026) Analysis & Trends

Werewolf Therapeutics has reported Prepaid Assets for 7 years, with the latest figure at $905000.0 in Q2 2026.

  • Prepaid Assets for Q2 2026 came in at $905000.0, down 68.17% year-over-year; the trailing twelve-month figure through Jun 2026 was $905000.0 (down 68.17% YoY), and the FY2025 annual result was $1.5 million, down 25.83% from the prior year.
  • Prepaid Assets slipped to $905000.0 in Q2 2026, from $2.3 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $6.8 million in Q3 2022 and troughed at $905000.0 in Q2 2026.
  • A 5-year average of $2.9 million and a median of $2.5 million in 2024 frame the typical range for Prepaid Assets.
  • The widest annual swing landed in 2022, when Prepaid Assets surged 555.89%; it then tumbled 68.17% in 2026.
  • A 5-year view of Prepaid Assets shows it stood at $4.0 million in 2022, then tumbled by 32.35% to $2.7 million in 2023, then slipped by 22.64% to $2.1 million in 2024, then retreated by 25.83% to $1.5 million in 2025, then tumbled by 41.08% to $905000.0 in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $905000.0 in Q2 2026, $2.3 million in Q1 2026, and $1.5 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Werewolf Therapeutics 43.94 Mn 43.94 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 905,000.00
Mar 31, 2026 2.28 Mn
Dec 31, 2025 1.54 Mn
Sep 30, 2025 2.46 Mn
Jun 30, 2025 2.84 Mn
Mar 31, 2025 2.42 Mn
Dec 31, 2024 2.07 Mn
Sep 30, 2024 2.54 Mn
Jun 30, 2024 2.94 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 2.68 Mn
Sep 30, 2023 3.29 Mn
Jun 30, 2023 3.02 Mn
Mar 31, 2023 2.44 Mn
Dec 31, 2022 3.96 Mn
Sep 30, 2022 6.84 Mn
Jun 30, 2022 6.23 Mn
Mar 31, 2022 1.73 Mn
Dec 31, 2021 3.54 Mn
Sep 30, 2021 3.97 Mn